Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Candel Therapeutics, Inc. (CADL) had Tangible Shareholders Equity of $80.12M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-11.27M |
|
-- |
|
-- |
|
$13.21M |
|
$-13.21M |
|
$1.94M |
|
$-11.27M |
|
$-11.27M |
|
$-11.27M |
|
$-11.27M |
|
$-11.27M |
|
$-11.27M |
|
$-13.21M |
|
$-13.01M |
|
54.89M |
|
54.89M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$90.13M |
|
$1.36M |
|
$3.46M |
|
$93.60M |
|
$10.93M |
|
$0.97M |
|
$2.54M |
|
$13.47M |
|
$80.12M |
|
|
Tangible Shareholders Equity |
$80.12M |
$80.12M |
|
54.90M |
|
| Cash Flow Statement Financials | |
$-27.74M |
|
$-0.15M |
|
$12.20M |
|
$102.92M |
|
$87.23M |
|
$-15.69M |
|
$2.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.25 |
|
-- |
|
-- |
|
0.01 |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.06% |
|
-14.06% |
|
-12.04% |
|
-13.90% |
|
$1.46 |
|
$-0.51 |
|
$-0.51 |
|